NCT00014261View on ClinicalTrials.gov

Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2000

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

PEG-interferon alfa-2b

DRUG

temozolomide

Trial Locations (1)

03756-0002

Norris Cotton Cancer Center, Lebanon

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00014261 - Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter